Follow up of Autoantibodies in Active Tuberculosis
NCT00551226 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2007-10-30
Summary
We have previoulsy shown that patients with active Tuberculosis develop a wide array of autoantibodies including rheumatoid factor, anti-CCP, Antinuclear facyor and anti Sm antibodies. The purpose of this study is to evaluate whether the level of autoantibodies decrease after treatment aganist tuberculosis.
Conditions
Sponsors & Collaborators
-
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Principal Investigators
-
Ori Elkayam, M.D · Tel Aviv Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-11-30
- Completion
- 2008-11-30
Countries
- Israel
Study Locations
More Related Trials
-
Paradoxical Reactions in Non Immuno-compromized Patients With Extrapulmonary Tuberculosis
NCT01252992 ·Status: COMPLETED
-
TB and Sarcoidosis Granuloma
NCT06396910 ·Status: COMPLETED
-
Expression of Tuberculosis in the Lung
NCT00201253 ·Status: COMPLETED
-
Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis
NCT00173264 ·Status: UNKNOWN
-
Characterization and Evaluation of Diagnostic Biomarkers for Tuberculosis
NCT01269268 ·Status: COMPLETED
-
The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection
NCT01685905 ·Status: UNKNOWN
-
Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT
NCT03220464 ·Status: UNKNOWN ·Phase: NA
-
Cytokines and Acute Phase Reactants as Markers of Pulmonary Tuberculosis Treatment
NCT00517231 ·Status: WITHDRAWN
-
Immunology Dysregulation in Lymphadenitis Tuberculosis : An Observational Study Using Patient' Block Paraffins 2019 Until 2021
NCT05202548 ·Status: COMPLETED
-
Predicting the Future: Incipient Tuberculosis
NCT04825327 ·Status: COMPLETED
-
TuBerculosis Viability Interregional Study and Agreement on Biological Tests
NCT04968886 ·Status: UNKNOWN
-
A Retrospective Cohort Study to Develop Markers for TB Severity and Treatment Progress
NCT05477966 ·Status: UNKNOWN
-
Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children
NCT00456469 ·Status: UNKNOWN
-
The Correlate of Risk Targeted Intervention Study
NCT02735590 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary Tuberculosis
NCT00926601 ·Status: UNKNOWN
-
Autoantibodies Against Specific Cytokines in Adults With Severe Mycobacterial Infection
NCT01628744 ·Status: UNKNOWN
-
TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB
NCT03251196 ·Status: UNKNOWN
-
Proportion of Clinical Improvement & Type 1 Interferon (IFN) Score Changes in Idiopathic Uveitis Patients With Interferon Gamma Release Assay (IGRA) Positive
NCT04088019 ·Status: RECRUITING
-
Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha Therapy
NCT00925249 ·Status: UNKNOWN
-
Surveillance and Follow-up for Latent Tuberculosis Infection and Observation of the Effect of Prophylactic Latent Tuberculosis Treatment in Patients With Severe Chronic Kidney Disease or Receiving Long-term Dialysis
NCT01685086 ·Status: UNKNOWN
-
NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis
NCT02371681 ·Status: COMPLETED ·Phase: PHASE2
-
Labial Biopsy in Patients With Tuberculosis Disease
NCT02115854 ·Status: COMPLETED
-
Prospective Study of Immune Function and PD-1 Antibody Therapy Efficacy Predictors on CAEBV and EBV-HLH Patients
NCT05841342 ·Status: UNKNOWN
-
Tuberculosis - Learning the Impact of Nutrition
NCT03598842 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TB
NCT01099098 ·Status: COMPLETED